Yuki Koga

Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory <i>BRAF</i> V600–Mutant Pediatric High-Grade Glioma

Darren Hargrave, Keita Terashima, Junichi Hara et al. · Journal of Clinical Oncology · 2023 · 66 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer

Yuki Kiyozumi, Masaaki Iwatsuki, Junji Kurashige et al. · International Journal of Cancer · 2018 · 40 citations · Full text

Medicine, Molecular Biology, Oncology +16

Can PD-L1 expression evaluated by biopsy sample accurately reflect its expression in the whole tumour in gastric cancer?

Kohei Yamashita, Masaaki Iwatsuki, Kazuto Harada et al. · British Journal of Cancer · 2019 · 39 citations · Full text

Medicine, Oncology, Pathology +17

Enhancement of transdermal protein delivery by photothermal effect of gold nanorods coated on polysaccharide-based hydrogel

Aung Thu Haine, Yuki Koga, Yuta Hashimoto et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2017 · 34 citations

Natural Sciences, Bioengineering, Biomedical Engineering +17

Prognostic Factors of Salvage Esophagectomy for Residual or Recurrent Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy

Yuki Kiyozumi, Naoya Yoshida, Takatsugu Ishimoto et al. · World Journal of Surgery · 2018 · 32 citations

Medicine, Oncology, Surgery +13